Peter Hendricks: Clinical Trials

1 trial sponsored by Peter Hendricks, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Peter Hendricks: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin for Methamphetamine Use Disorder
Psilocybin (single oral capsule administered at one of two dose levels, Dose A or Dose B; specific doses withheld during conduct)., Manualized cognitive behavioral therapy platform (2 preparation + 2 integration sessions). - Methamphetamine Use Disorder
Phase 2Not yet recruitingPeter Hendricks422027-02-012026-09-21

Conditions studied

Substance-Related Disorders (1)

Interventions

Floors and Floorcoverings (1)  ·  Psilocybin (1)

Countries

United States (1)

Top investigators

Peter S Hendricks, PhD (1)

NIH funding

1UG3DA067126 (1)